Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
0.00 (0.00%)
Oct 7, 2026, 3:45 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 16.7 million as of October 7, 2026. That makes Atomo Diagnostics the world's 40,799th most valuable company and 1,165th in Australia. Its market cap has decreased by 31.31% in one year.
Market Cap
16.70M
Enterprise Value
13.36M
Revenue
5.33M
Global Rank
Country Rank
#1,165 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 16.70M, a decrease of -92.37%. That is a compound annual growth rate of -32.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 16.70M | -42.76% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 49.82M |
| Cleo Diagnostics | 47.99M |
| Micro-X | 40.63M |
| CleanSpace Holdings | 39.68M |
| Nova Eye Medical | 38.46M |
| Control Bionics | 35.30M |
| OncoSil Medical | 26.24M |
| ImpediMed | 21.97M |